The mediating role of cytokine IL-6 on the relationship of FEV₁ upon 6-minute walk distance in chronic obstructive pulmonary disease

Int J Chron Obstruct Pulmon Dis. 2014 Oct 7:9:1091-9. doi: 10.2147/COPD.S57845. eCollection 2014.

Abstract

Objectives: To explore the mediating role of protein interleukin-6 (IL-6) on the relationship between forced expiratory volume in 1 second (FEV1) and 6-minute walk distance (6MWD) and, further, to determine whether status variables (such as age, sex, and body mass index [BMI]) operate as moderators of this mediation relationship.

Design: Moderated mediation model.

Setting: An inpatient pulmonary rehabilitation center in Italy.

Participants: All 153 patients involved in the screening of a randomized controlled clinical trial (ClinicalTrials.gov identifier: NCT01253941) were included in this study. All patients were Global initiative for chronic Obstructive Lung Disease (GOLD) stages I-IV and were aged 70.1±9.1 years.

Measurements: At run-in phase of the protocol, clinical and functional screening included BMI, fasting plasma levels of protein (IL-6), spirometry, and standardized 6-minute walking test, measured at the start of the respiratory rehabilitation program.

Methods: The size of the indirect effect of the initial variable (FEV1) upon the outcome variable (6MWD) through the intervening variable (IL-6) was computed and tested for statistical significance. Moderated mediation analyses were subsequently conducted with age, sex, and BMI.

Results: FEV1 averaged 53.4%±21.2%, and 6MWD 66.4%±41.3% of predicted. Median protein IL-6 was 6.68 pg/mL (interquartile range: 5.96). A bootstrapped mediation test supported the predicted indirect pathway (P=0.003). The indirect effect through IL-6 log units accounted for 17% of the total effect between FEV1 and 6MWD. Age functioned as a significant moderator of the mediational pattern. For individuals aged <70 years, the standardized indirect effect was significant (0.122, 95% confidence interval [CI]: 0.044-0.254, P=0.004), and for individuals >70 years it was not significant (0.04, 95% CI: -0.010 to 0.142, P=0.10).

Conclusion: This moderated mediation result based on concurrent data suggests, but does not prove, a causal role of systemic inflammatory syndrome on progression from functional impairment to "frailty" status and substantial disability in aging chronic obstructive pulmonary disease.

Keywords: COPD; aging; chronic airflow obstruction; mediation analysis.

MeSH terms

  • Age Factors
  • Aged
  • Biomarkers / blood
  • Body Mass Index
  • Exercise Test*
  • Exercise Tolerance*
  • Female
  • Forced Expiratory Volume*
  • Humans
  • Inflammation Mediators / blood*
  • Inpatients
  • Interleukin-6 / blood*
  • Italy
  • Lung / immunology
  • Lung / physiopathology*
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Pulmonary Disease, Chronic Obstructive / blood*
  • Pulmonary Disease, Chronic Obstructive / immunology
  • Pulmonary Disease, Chronic Obstructive / physiopathology*
  • Pulmonary Disease, Chronic Obstructive / rehabilitation
  • Rehabilitation Centers
  • Severity of Illness Index
  • Spirometry
  • Time Factors
  • Walking*

Substances

  • Biomarkers
  • IL6 protein, human
  • Inflammation Mediators
  • Interleukin-6

Associated data

  • ClinicalTrials.gov/NCT01253941